For: | Li X, Nie J, Mei Q, Han WD. MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma. World J Gastroenterol 2016; 22(23): 5317-5331 [PMID: PMC4910653 DOI: 10.3748/wjg.v22.i23.5317] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i23/5317.htm |
Number | Citing Articles |
1 |
Jian Wang, Huaqiang Liu, Lin Tian, Fachen Wang, Liangbo Han, Wei Zhang, Yun-an Bai. miR-15b Inhibits the Progression of Glioblastoma Cells Through Targeting Insulin-like Growth Factor Receptor 1. Hormones and Cancer 2017; 8(1): 49 doi: 10.1007/s12672-016-0276-z
|
2 |
Mahmoud A. Elrebehy, Sarah Al-Saeed, Sara Gamal, Asmaa El-Sayed, Alshaimaa A. Ahmed, Omnia Waheed, Ahmed Ismail, Hesham A. El-Mahdy, Al-Aliaa M. Sallam, Ahmed S. Doghish. miRNAs as cornerstones in colorectal cancer pathogenesis and resistance to therapy: A spotlight on signaling pathways interplay — A review. International Journal of Biological Macromolecules 2022; 214: 583 doi: 10.1016/j.ijbiomac.2022.06.134
|
3 |
Kengo Kuroda, Tomokazu Fukuda, Marija Krstic-Demonacos, Constantinos Demonacos, Kazuhiko Okumura, Hiroshi Isogai, Miwa Hayashi, Kazuki Saito, Emiko Isogai. miR-663a regulates growth of colon cancer cells, after administration of antimicrobial peptides, by targeting CXCR4-p21 pathway. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-016-3003-9
|
4 |
Yong Wang, Zhi Lu, Ningnin Wang, Jianzhou Feng, Junjie Zhang, Lan Luan, Wei Zhao, Xiandong Zeng. Long noncoding RNA DANCR promotes colorectal cancer proliferation and metastasis via miR-577 sponging. Experimental & Molecular Medicine 2018; 50(5): 1 doi: 10.1038/s12276-018-0082-5
|
5 |
Ting Ji, Weiguang Feng, Xiangcheng Zhang, Kui Zang, Xingxing Zhu, Futai Shang. HDAC inhibitors promote pancreatic stellate cell apoptosis and relieve pancreatic fibrosis by upregulating miR-15/16 in chronic pancreatitis. Human Cell 2020; 33(4): 1006 doi: 10.1007/s13577-020-00387-x
|
6 |
Lucien P. Garo, Amrendra K. Ajay, Mai Fujiwara, Galina Gabriely, Radhika Raheja, Chantal Kuhn, Brendan Kenyon, Nathaniel Skillin, Ryoko Kadowaki-Saga, Shrishti Saxena, Gopal Murugaiyan. MicroRNA-146a limits tumorigenic inflammation in colorectal cancer. Nature Communications 2021; 12(1) doi: 10.1038/s41467-021-22641-y
|
7 |
Dorothea Plundrich, Sophia Chikhladze, Stefan Fichtner-Feigl, Reinhild Feuerstein, Priscilla S. Briquez. Molecular Mechanisms of Tumor Immunomodulation in the Microenvironment of Colorectal Cancer. International Journal of Molecular Sciences 2022; 23(5): 2782 doi: 10.3390/ijms23052782
|
8 |
Yixin Yang, Christopher Alderman, Ayoub Sehlaoui, Yuan Xiao, Wei Wang. MicroRNAs as Immunotherapy Targets for Treating Gastroenterological Cancers. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/9740357
|
9 |
Zhongxu Zhu, Guiyuan Han, Hao Huang, Lingli He, Yu Chen, Jia Ke, Feng Gao, Louis Vermeulen, Xin Wang. Detection Methods in Precision Medicine. 2020; : 1 doi: 10.1039/9781788019958-00001
|
10 |
Javaid Ahmed Wani, Sabhiya Majid, Muneeb U. Rehman, Mosin Saleem Khan, Qadir Jasiya. Clinical Applications of Immunogenetics. 2022; : 165 doi: 10.1016/B978-0-323-90250-2.00008-X
|
11 |
Shushan Yan, Bing Han, Shunyuan Gao, Xiaochen Wang, Zengfang Wang, Fakai Wang, Jianjun Zhang, Donghua Xu, Beicheng Sun. Exosome-encapsulated microRNAs as circulating biomarkers for colorectal cancer. Oncotarget 2017; 8(36): 60149 doi: 10.18632/oncotarget.18557
|
12 |
Zaoqu Liu, Taoyuan Lu, Yanli Wang, Dechao Jiao, Zhaonan Li, Libo Wang, Long Liu, Chunguang Guo, Yanan Zhao, Xinwei Han. Establishment and experimental validation of an immune miRNA signature for assessing prognosis and immune landscape of patients with colorectal cancer. Journal of Cellular and Molecular Medicine 2021; 25(14): 6874 doi: 10.1111/jcmm.16696
|
13 |
Aleksandra Filipovic, George Miller, Joseph Bolen. Progress Toward Identifying Exact Proxies for Predicting Response to Immunotherapies. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00155
|
14 |
Taotao Shou, Huyin Yang, Jia Lv, Dai Liu, Xiaoyang Sun. MicroRNA‑3666 suppresses the growth and migration of glioblastoma cells by targeting KDM2A. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.9698
|
15 |
Zhaoxu Wu, Qiang Ju. Non-Coding RNAs Implicated in the Tumor Microenvironment of Colorectal Cancer: Roles, Mechanisms and Clinical Study. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.888276
|
16 |
Jinchun Cong, Jian Gong, Chuanjia Yang, Zhixiu Xia, Hong Zhang. <p>miR-22 Suppresses Tumor Invasion and Metastasis in Colorectal Cancer by Targeting NLRP3</p>. Cancer Management and Research 2020; : 5419 doi: 10.2147/CMAR.S255125
|
17 |
Lin Tan, Weiming Qu, Dajun Wu, Minji Liu, Qian Wang, Qiongjia Ai, Hongsai Hu, Min Chen, Weishun Chen, Hongbing Zhou, Hung Wei Pan. GRHL3 Promotes Tumor Growth and Metastasis via the MEK Pathway in Colorectal Cancer. Analytical Cellular Pathology 2021; 2021: 1 doi: 10.1155/2021/6004821
|
18 |
Sagari Sil, Janet Bertilla, S. Rupachandra. A comprehensive review on RNA interference-mediated targeting of interleukins and its potential therapeutic implications in colon cancer. 3 Biotech 2023; 13(1) doi: 10.1007/s13205-022-03421-x
|
19 |
G Jin, Y Yang, K Liu, J Zhao, X Chen, H Liu, R Bai, X Li, Y Jiang, X Zhang, J Lu, Z Dong. Combination curcumin and (−)-epigallocatechin-3-gallate inhibits colorectal carcinoma microenvironment-induced angiogenesis by JAK/STAT3/IL-8 pathway. Oncogenesis 2017; 6(10): e384 doi: 10.1038/oncsis.2017.84
|
20 |
Ingrid Garajová, Manuela Ferracin, Elisa Porcellini, Andrea Palloni, Francesca Abbati, Guido Biasco, Giovanni Brandi. Non-Coding RNAs as Predictive Biomarkers to Current Treatment in Metastatic Colorectal Cancer. International Journal of Molecular Sciences 2017; 18(7): 1547 doi: 10.3390/ijms18071547
|
21 |
Takaaki Masuda, Naoki Hayashi, Yosuke Kuroda, Shuhei Ito, Hidetoshi Eguchi, Koshi Mimori. MicroRNAs as Biomarkers in Colorectal Cancer. Cancers 2017; 9(9): 124 doi: 10.3390/cancers9090124
|
22 |
María Antonia Lizarbe, Jorge Calle-Espinosa, Eva Fernández-Lizarbe, Sara Fernández-Lizarbe, Miguel Ángel Robles, Nieves Olmo, Javier Turnay. Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/7354260
|
23 |
Ying Yang, Wen-Jian Meng, Zi-Qiang Wang. MicroRNAs in Colon and Rectal Cancer - Novel Biomarkers from Diagnosis to Therapy. Endocrine, Metabolic & Immune Disorders - Drug Targets 2020; 20(8): 1211 doi: 10.2174/1871530320666200506075219
|
24 |
Fei Wang, Peng Li, Ying Feng, Yi-Lin Hu, Yi-Fei Liu, Yi-Bing Guo, Xin-Lin Jiang, Qin-Sheng Mao, Wan-Jiang Xue. Low expression of RASSF10 is associated with poor survival in patients with colorectal cancer. Human Pathology 2017; 62: 108 doi: 10.1016/j.humpath.2016.12.016
|
25 |
Lui Ng, Xue Li, Timothy Ming-Hun Wan, Deepak Iyer, Ryan Wai-Yan Sin, Oswens Siu-Hung Lo, Dominic Chi-Chung Foo, Wai-Lun Law. Investigation of miRNA dysregulation and association with immune cell profile during malignant transformation of colorectal cells. European Journal of Surgical Oncology 2022; 48(1): 245 doi: 10.1016/j.ejso.2021.09.016
|
26 |
Pramod Darvin, Salman M. Toor, Varun Sasidharan Nair, Eyad Elkord. Immune checkpoint inhibitors: recent progress and potential biomarkers. Experimental & Molecular Medicine 2018; 50(12): 1 doi: 10.1038/s12276-018-0191-1
|
27 |
Marcela Alcântara Proença, Joice Matos Biselli, Maysa Succi, Fábio Eduardo Severino, Gustavo Noriz Berardinelli, Alaor Caetano, Rui Manuel Reis, David J Hughes, Ana Elizabete Silva. Relationship between <i>Fusobacterium nucleatum</i>, inflammatory mediators and microRNAs in colorectal carcinogenesis. World Journal of Gastroenterology 2018; 24(47): 5351-5365 doi: 10.3748/wjg.v24.i47.5351
|
28 |
Sridhar Muthusami, Ileng Kumaran Ramachandran, Kokelavani Nampalli Babu, Sneha Krishnamoorthy, Akash Guruswamy, Lurdes Queimado, Gautam Chaudhuri, Ilangovan Ramachandran. Role of Inflammation in the Development of Colorectal Cancer. Endocrine, Metabolic & Immune Disorders - Drug Targets 2021; 21(1): 77 doi: 10.2174/1871530320666200909092908
|
29 |
Jingmei Lin, Chia-Chen Chuang, Li Zuo. Potential roles of microRNAs and ROS in colorectal cancer: diagnostic biomarkers and therapeutic targets. Oncotarget 2017; 8(10): 17328 doi: 10.18632/oncotarget.14461
|
30 |
Dan He, Zhong-bao Ruan, Gui-xian Song, Ge-cai Chen, Fei Wang, Mei-xiang Wang, Mao-kun Yuan, Li Zhu. miR-15a-5p regulates myocardial fibrosis in atrial fibrillation by targeting Smad7. PeerJ 2021; 9: e12686 doi: 10.7717/peerj.12686
|
31 |
Haseeb Ahsan, Salman Ul Islam, Muhammad Bilal Ahmed, Young Sup Lee, Mughal Qayum, Jong Kyung Sonn. Cancer Biomarkers in Diagnosis and Therapeutics. 2022; : 229 doi: 10.1007/978-981-16-5759-7_9
|
32 |
Wenjiong Hao, Wei Luo, Mangmang Bai, Jian Li, Xiaobin Bai, Jie Guo, Jinsong Wu, Maode Wang. MicroRNA-206 Inhibited the Progression of Glioblastoma Through BCL-2. Journal of Molecular Neuroscience 2016; 60(4): 531 doi: 10.1007/s12031-016-0824-6
|
33 |
Su Jili, Lu Eryong, Lu Lijuan, Zhang Chao. RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR‐148a‐3p/DNMT1 axis. Cell Biochemistry and Function 2016; 34(8): 597 doi: 10.1002/cbf.3233
|
34 |
Tong Li, Wenjuan Zhou, Yimin Li, Yaqi Gan, Yulong Peng, Qing Xiao, Chunli Ouyang, Anqi Wu, Sai Zhang, Jiaqi Liu, Lili Fan, Duo Han, Yu Wei, Guang Shu, Gang Yin, Klaus Roemer. MiR-4524b-5p/WTX/β-catenin axis functions as a regulator of metastasis in cervical cancer. PLOS ONE 2019; 14(4): e0214822 doi: 10.1371/journal.pone.0214822
|
35 |
N. C. Patel, A. P. Patel, J. K. Patel. DEVELOPMENT AND VALIDATION OF CHEMOMETRIC-ASSISTED UV-SPECTROPHOTOMETRIC METHOD FOR EPIGALLOCATECHIN GALLATE AND CURCUMIN IN TABLET FORMULATION. INDIAN DRUGS 2020; 57(04): 45 doi: 10.53879/id.57.04.12286
|
36 |
Yunhui Qu, Hongtao Liu, Xinquan Lv, Yuqiong Liu, Xiaojuan Wang, Min Zhang, Xiaqing Zhang, Yuenan Li, Qianqian Lou, Shenglei Li, Huixiang Li. MicroRNA-16-5p overexpression suppresses proliferation and invasion as well as triggers apoptosis by targeting VEGFA expression in breast carcinoma. Oncotarget 2017; 8(42): 72400 doi: 10.18632/oncotarget.20398
|
37 |
Maria Braoudaki, Mohammed Saqif Ahmad, Denis Mustafov, Sara Seriah, Mohammad Naseem Siddiqui, Shoib Sarwar Siddiqui. Chemokines and chemokine receptors in colorectal cancer; multifarious roles and clinical impact. Seminars in Cancer Biology 2022; 86: 436 doi: 10.1016/j.semcancer.2022.06.002
|
38 |
Milena Peruhova, Monika Peshevska-Sekulovska, Boris Krastev, Gabriela Panayotova, Viktoriya Georgieva, Rossitza Konakchieva, Georgi Nikolaev, Tsvetelina Veselinova Velikova. What could microRNA expression tell us more about colorectal serrated pathway carcinogenesis?. World Journal of Gastroenterology 2020; 26(42): 6556-6571 doi: 10.3748/wjg.v26.i42.6556
|
39 |
Yuandong Zhu, Jianjion Li, Haiyuan Liu, Zhengming Song, Qinghua Yang, Chengdong Lu, Wenbin Chen. Circular RNA, hsa_circRNA_102049, promotes colorectal cancer cell migration and invasion via binding and suppressing miRNA‑455‑3p. Experimental and Therapeutic Medicine 2022; 23(3) doi: 10.3892/etm.2022.11169
|
40 |
Zahraa Isam Jameel. Four microRNA gene polymorphisms are associated with Iraqi patients with colorectal cancer. Egyptian Journal of Medical Human Genetics 2024; 25(1) doi: 10.1186/s43042-024-00521-6
|
41 |
Alexandre Perrier, Audrey Didelot, Pierre Laurent-Puig, Hélène Blons, Simon Garinet. Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors. Biomolecules 2020; 10(7): 1061 doi: 10.3390/biom10071061
|
42 |
Toshimi Otsuka, Tomomitsu Tahara, Masakatsu Nakamura, Wu Jing, Masafumi Ota, Tomoe Nomura, Ranji Hayashi, Takeo Shimasaki, Tomoyuki Shibata, Tomiyasu Arisawa. Polymorphism rs7521584 in miR‑429 is associated with the severity of atrophic gastritis in patients with Helicobacter�pylori infection. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.9200
|
43 |
Giuseppe Sammarco, Gaetano Gallo, Giuseppina Vescio, Arcangelo Picciariello, Gilda De Paola, Mario Trompetto, Giuseppe Currò, Michele Ammendola. Mast Cells, microRNAs and Others: The Role of Translational Research on Colorectal Cancer in the Forthcoming Era of Precision Medicine. Journal of Clinical Medicine 2020; 9(9): 2852 doi: 10.3390/jcm9092852
|
44 |
Alihossein Saberi, Daryoush Shahbazi-Gahrouei, Mahdi Abbasian, Mehrafarin Fesharaki, Azam Baharlouei, Zahra Arab-Bafrani. Gold nanoparticles in combination with megavoltage radiation energy increased radiosensitization and apoptosis in colon cancer HT-29 cells. International Journal of Radiation Biology 2017; 93(3): 315 doi: 10.1080/09553002.2017.1242816
|
45 |
Daqiong Jiang, Huiyan Wang, Zhuyan Li, Zhen Li, Xin Chen, Hongbing Cai. MiR-142 inhibits the development of cervical cancer by targeting HMGB1. Oncotarget 2017; 8(3): 4001 doi: 10.18632/oncotarget.13136
|
46 |
Yoshitaro Shindo, Shoichi Hazama, Ryouichi Tsunedomi, Nobuaki Suzuki, Hiroaki Nagano. Novel Biomarkers for Personalized Cancer Immunotherapy. Cancers 2019; 11(9): 1223 doi: 10.3390/cancers11091223
|